This compound is widely used in the pharmaceutical industry as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). It plays a significant role in the production of drugs targeting central nervous system disorders, including antidepressants and antipsychotics. Its trifluoromethyl group enhances the metabolic stability and bioavailability of the final drug molecules. Additionally, it is utilized in organic synthesis for constructing complex molecules due to its ability to introduce chiral centers, which are crucial for the development of enantioselective drugs. In research, it serves as a building block for studying the effects of fluorinated compounds in medicinal chemistry.